🐜
|
Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study.
29 auth.
V. Morris,
M. Salem,
H. Nimeiri,
S. Iqbal,
Preet Paul Singh,
K. Ciombor,
B. Polite,
D. Deming,
E. Chan,
J. Wade,
Lianchun Xiao,
T. Bekaii-Saab,
L. Vence,
J. Blando,
A. Mahvash,
...
W. Foo,
Chimela Ohaji,
Manolo Pasia,
G. Bland,
A. Ohinata,
J. Rogers,
A. Mehdizadeh,
K. Banks,
R. Lanman,
R. Wolff,
H. Streicher,
J. Allison,
Padmanee Sharma,
C. Eng
|
8 |
2017 |
8 🐜
|
🐜
|
A randomized study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors: A trial of the ECOG-ACRIN Cancer Research Group (E2211).
17 auth.
P. Kunz,
P. Catalano,
H. Nimeiri,
G. Fisher,
T. Longacre,
Carlos J. Suarez,
James C. Yao,
M. Kulke,
A. Hendifar,
J. Shanks,
...
M. Shah,
M. Zalupski,
E. Schmulbach,
D. Reidy,
J. Strosberg,
P. O'dwyer,
A. Benson
|
7 |
2015 |
7 🐜
|
🐜
|
Ipilimumab and Gemcitabine for Advanced Pancreatic Cancer: A Phase Ib Study.
7 auth.
Suneel D. Kamath,
A. Kalyan,
S. Kircher,
H. Nimeiri,
Angela J. Fought,
A. Benson,
...
M. Mulcahy
|
7 |
2019 |
7 🐜
|
🦁
|
Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: a trial of the Chicago, PMH, and California Phase II Consortia.
10 auth.
H. Nimeiri,
A. Oza,
R. Morgan,
G. Friberg,
K. Kasza,
L. Faoro,
...
R. Salgia,
W. Stadler,
E. Vokes,
G. Fleming
|
7 |
2008 |
7 🦁
|
🐜
|
Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial
28 auth.
K. Ng,
H. Nimeiri,
N. McCleary,
T. Abrams,
M. Yurgelun,
J. Cleary,
D. Rubinson,
D. Schrag,
R. Miksad,
A. Bullock,
Jill N. Allen,
D. Zuckerman,
E. Chan,
J. Chan,
B. Wolpin,
...
Michael Constantine,
D. Weckstein,
Meredith A. Faggen,
C. Thomas,
C. Kournioti,
C. Yuan,
Christine Ganser,
Brittney Wilkinson,
C. Mackintosh,
Hui Zheng,
B. Hollis,
J. Meyerhardt,
C. Fuchs
|
7 |
2019 |
7 🐜
|
🐜
|
Nab-Paclitaxel and Gemcitabine as First-line Treatment of Advanced or Metastatic Cholangiocarcinoma: A Phase 2 Clinical Trial
9 auth.
V. Sahai,
P. Catalano,
M. Zalupski,
S. Lubner,
M. Menge,
H. Nimeiri,
...
H. Munshi,
A. Benson,
P. O'dwyer
|
6 |
2018 |
6 🐜
|
🦁
|
A phase II study of sorafenib in advanced uterine carcinoma/carcinosarcoma: a trial of the Chicago, PMH, and California Phase II Consortia.
10 auth.
H. Nimeiri,
A. Oza,
R. Morgan,
D. Huo,
L. Elit,
J. Knost,
...
J. Wade,
E. Agamah,
E. Vokes,
G. Fleming
|
6 |
2010 |
6 🦁
|
🐜
|
Radioembolisation for liver metastases: results from a prospective 151 patient multi-institutional phase II study.
16 auth.
A. Benson,
J. Geschwind,
M. Mulcahy,
W. Rilling,
G. Siskin,
G. Wiseman,
J. Cunningham,
B. Houghton,
M. Ross,
Khairuddin Memon,
...
J. Andrews,
C. Fleming,
J. Herman,
H. Nimeiri,
R. Lewandowski,
R. Salem
|
6 |
2013 |
6 🐜
|
🐜
|
Twelve-year experience of radioembolization for colorectal hepatic metastases in 214 patients: survival by era and chemotherapy
20 auth.
R. Lewandowski,
Khairuddin Memon,
M. Mulcahy,
R. Hickey,
Karen Marshall,
Melissa Williams,
Krystina Salzig,
V. Gates,
Bassel Atassi,
M. Vouche,
...
Rohi Atassi,
K. Desai,
E. Hohlastos,
Kent T. Sato,
A. Habib,
S. Kircher,
S. Newman,
H. Nimeiri,
A. Benson,
R. Salem
|
6 |
2014 |
6 🐜
|
🐜
|
90Y Radioembolization of Colorectal Hepatic Metastases Using Glass Microspheres: Safety and Survival Outcomes from a 531-Patient Multicenter Study
24 auth.
R. Hickey,
R. Lewandowski,
T. Prudhomme,
E. Ehrenwald,
B. Baigorri,
J. Critchfield,
J. Kallini,
A. Gabr,
B. Gorodetski,
J. Geschwind,
...
A. Abbott,
R. Shridhar,
S. White,
W. Rilling,
B. Boyer,
S. Kauffman,
S. Kwan,
S. Padia,
V. Gates,
M. Mulcahy,
S. Kircher,
H. Nimeiri,
A. Benson,
R. Salem
|
6 |
2016 |
6 🐜
|